E
Ensysce Biosciences Inc (ENSC)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
$0.42
+0.03 (+8.06%)
Market Cap: $8.14M
Last updated: Nov 17, 2026 at 11:03 AM ET
Ensysce Biosciences Inc (ENSC) Valuation Multiples
Ensysce Biosciences (ENSC) trades at 1.2x sales and 0.3x book value. Its forward P/E is 0.9x.
Current Multiples
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | 0.9x |
| Price to sales | 1.2x |
| Price to book | 0.3x |
| PEG | N/A |
Valuation History
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $0.92 | N/A | 0.5x | 7.3x |
| 2024 | $8.14 | N/A | N/A | 2.7x |
| 2023 | $15.89 | N/A | 0.9x | N/A |
| 2022 | $134.99 | N/A | N/A | N/A |
| 2021 | $16,918.31 | N/A | N/A | N/A |
| 2020 | $44,760.45 | N/A | N/A | N/A |
| 2019 | $37,508.26 | 154.5x | N/A | N/A |
| 2018 | $35,348.47 | N/A | N/A | N/A |
Frequently Asked Questions About ENSC
What is ENSC's forward P/E ratio?
Ensysce Biosciences has a forward P/E ratio of 0.9x.
What is ENSC's price to sales ratio?
Ensysce Biosciences has a price to sales ratio of 1.2x.
ENSC pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors